Category: Business

  • Moderna to build UK’s first mRNA vaccine research and manufacturing centre

    Boston-based biotech firm agrees £1bn deal with government for centre to combat Covid and other illnesses The Boston-based biotech Moderna is to build the UK’s first research and manufacturing centre dedicated to the development of mRNA vaccines against new Covid variants and other respiratory illnesses, in an effort to improve readiness for future pandemics. Under […]

  • For haemophiliacs, most of the world is still living in the dark ages

    A sufferer explains how the differences in treatment between the UK and his native India highlight a global medical apartheid Like the Hindu deity Krishna, I was born with blue skin. My body bruised at the trauma of simply being held. And so the family arranged for a ritual to appease the gods. Haemophilia is […]

  • The WTO faces a make or break week over vaccines | Larry Elliott

    A ruling on whether or not to waive patent rules will this week show if the trade body is for the world or the west A crisis at the World Trade Organization has been brewing for years and it now looks like coming to a head. There are many potential flash points as trade ministers […]

  • Drugmakers urged to give poorer nations access to more antibiotics

    Antifungals also needed, says study, as drug resistance has increased faster than expected, particularly in sub-Saharan Africa Drugmakers are being urged to make more antibiotics and antifungal drugs available to low- and middle-income countries as drug resistance rises faster than expected globally. Infections that are resistant to drugs can spread rapidly without people’s access to […]

  • Pfizer to offer low-cost medicines to 45 lower-income countries

    Firm launches ‘healthier world’ accord in Davos and speaks to other drugmakers about similar steps Pfizer has announced it is to supply all its current and future patent-protected medicines and vaccines on a not-for-profit basis to 45 lower-income countries and is talking to other big drugmakers about similar steps. Announcing the “accord for a healthier […]

  • AstraZeneca reviews diversity in trials to ensure drugs work for all

    Firm aims to apply ‘equity lens’ across clinical tests to ensure diverse population groups take part The pharmaceutical giant AstraZeneca is conducting a major review of diversity across its trials in an attempt to ensure its medicines work for all population groups, although it has admitted that including pregnant women is a particular challenge. The […]

  • ‘Pharma Bro’ Martin Shkreli released from prison early

    After his company acquired Daraprim, it raised price of the life-saving drug by 5,000%, prompting national outcry Martin Shkreli, the “Pharma Bro” entrepreneur who astronomically increased the price of a life-saving drug by 5,000%, and became a symbol of corporate Wall Street greed, has been released from prison. In a statement released on Wednesday, the […]

  • HRT products could be sent to UK from mainland Europe next week

    Regulator expected to consent to import of hormone replacement pills and patches from France Extra supplies of hormone replacement therapy products could be shipped to the UK from France and Poland as soon as next week, a major manufacturer has said after crisis meetings were held to address the nationwide shortage. Tina Backhouse, the general […]

  • Boots, Superdrug and other chemists report hay fever pill shortages

    GlaxoSmithKline blames shortage of key ingredient for lack of Piriton and Piriteze tablets Big high street pharmacy chains including Boots and Superdrug have run out of some hay fever medicines, with the manufacturer, GlaxoSmithKline, blaming temporary supply issues. Piriton and Piriteze tablets, made by GSK, are out of stock at Boots and other chains because […]

  • Inside one of the first licensed medical cannabis labs in Britain

    Under tightly controlled conditions, Celadon Pharmaceuticals’ site will initially focus on chronic pain treatments A sweet smell wafts through the air, as two men weave through the small room tightly packed with cannabis plants, growing high above their shoulders in a flush of intoxicating flora. This isn’t yet another illegal weed factory but one of […]

  • ‘My pain levels have completely dropped’: how medical marijuana changed my life

    Andrea Wright, diagnosed with psoriatic arthritis and fibromyalgia, is now having a proper night’s sleep Andrea Wright, 39, from Bristol, was diagnosed in 2013 with psoriatic arthritis and fibromyalgia, a long-term condition that causes pain all over the body. She was in such severe constant pain, and unable to sleep for more than two continuous […]

  • Sajid Javid in crisis talks over HRT shortages

    Health secretary calls meeting with industry representatives and government’s new HRT supply tsar Why is the UK suffering HRT shortages? – podcast The UK’s acute shortage of hormone replacement therapy products for menopausal women has prompted the health secretary to call a meeting with industry representatives and and the government’s new HRT supply tsar to […]

  • Radical plans to transform NHS drawn up at drug firms and No 10 roundtable

    Exclusive: ideas include reducing trial safeguards and allowing startups to harvest patient data A list of radical ideas for transforming the NHS, including lifting safeguards blocking startups’ access to patient data, and nurses being incentivised to help speed trials, was privately drawn up by drug and healthcare companies in talks with senior No 10 advisers. […]

  • Hopes rise for Covid vaccine patent waiver after key countries agree on proposal

    The proposal, if passed by the full council, could allow other countries to make vaccines without paying pharmaceutical companies The World Trade Organization’s (WTO) most powerful members said on Tuesday that they had agreed on a proposed waiver on intellectual property rights for Covid-19 vaccines in the hopes of speeding up rollouts worldwide. The proposal […]

  • Pfizer accused of Covid profiteering as first-quarter sales hit $26bn

    Pharma firm criticised over pricing and for keeping monopoly control over vaccine and new Paxlovid pill See all our coronavirus coverage Pfizer has made nearly $26bn (£21bn) in revenues in the first three months of the year, the bulk from its Covid-19 vaccine and new pill to treat the virus, prompting fresh accusations of pandemic […]

  • AstraZeneca boss calls for UK to provide new Covid-19 medicine to the vulnerable

    Pharmaceutical CEO says it’s ‘sad’ that UK has failed to order Evusheld for the immunosuppressed AstraZeneca boss Pascal Soriot has called on the government to provide access to its Covid-19 medicine Evusheld, saying it’s a “sad situation” that Britain is one of the few developed nations not to have ordered the drug, designed for those […]

  • Johnson & Johnson shareholders called on to end talc baby powder sales

    Resolutions to be voted on at shareholder meeting including stopping global sales of product and racial justice audit Women’s health groups are calling on healthcare giant Johnson & Johnson’s largest shareholders to force the company to end all sales of its controversial talc-based baby powder and hire an independent firm to conduct a racial justice […]

  • What is HRT and why are there shortages in the UK?

    Britain is experiencing an acute shortage of hormone replacement therapy, which is used by about 1 million women in the UK The UK is currently experiencing an acute shortage of hormone replacement therapy (HRT). But what is HRT, and what is causing the shortages? Continue reading…

  • Pill to control ‘sudden urge to pee’ could be sold over the counter in UK

    Sufferers urged to join consultation after Aquiette pills deemed safe to buy without prescription Millions of women suffering from an overactive bladder have been urged to take part in a consultation that could make a treatment available over the counter for the first time. The call for evidence, launched on Saturday, could lead to the […]

  • Clinical trials: how taking the pills may pay those bills

    Volunteering to test new treatments can net up to £7,000 – enough to help offset the cost of living rise Fancy a relaxing two-week getaway where you get your travel expenses paid, plus your own en suite room with all mod cons including a TV, PlayStation games console and free wifi? What’s more, it won’t […]

  • Johnson & Johnson ordered to pay $302m over pelvic mesh implant ads

    California court rules that company made misleading and potentially harmful statements in hundreds of thousands of ads A California appeals court has upheld a lower court ruling that Johnson & Johnson must pay penalties to the state for deceptively marketing pelvic mesh implants for women. Johnson & Johnson had appealed in 2020 after superior court […]

  • GSK to buy US cancer drug developer amid pressure from activist investor

    GlaxoSmithKline’s £1.5bn Sierra Oncology deal comes after pressure to boost its pipeline from Elliott The UK drug company GlaxoSmithKline has agreed a £1.5bn deal to buy a US cancer treatment developer as it tries to fend off pressure from activist shareholder Elliott Management. The deal will give Britain’s second-largest pharmaceutical company access to California-based Sierra […]

  • Profits jump for Patel-backed PPE firm after it won £216m contracts

    Pharmaceuticals Direct Limited was awarded taxpayer-funded business after support from home secretary Profits at a PPE company that secured support from the home secretary, Priti Patel, as it lobbied ministers for UK government contracts have soared after winning £216m in taxpayer-funded business during the pandemic. Revenues at Pharmaceuticals Direct Limited jumped from £38m to £166m […]

  • LV= on board with £515,000 bonus for boss despite shambles of failed sale

    Mark Hartigan has been given £515,000 bonus for 2021 – a humbler CEO would have let the dust settle Mark Hartigan had his bonus for 2021, members of LV= may feel, when he got to keep his job as chief executive despite overseeing the shambles of the failed £530m sale of the mutual insurer to […]

  • AstraZeneca’s Evusheld Covid-prevention drug gets UK approval

    Treatment aimed at people who cannot be vaccinated is boost to firm’s coronavirus portfolio AstraZeneca has received UK regulatory approval for its long-acting Covid-19 antibody treatment Evusheld in a boost to its coronavirus portfolio as the British-Swedish drugmaker targets greater drug development success at its new £1bn research lab in Cambridge. Aimed at preventing Covid […]

  • GlaxoSmithKline says it will not start any new clinical trials in Russia

    Pharma firm joins AstraZeneca and Pfizer in saying it will not enrol new patients into studies Russia-Ukraine war: latest updates What we know on day 22 of the invasion GlaxoSmithKline has joined other drugmakers in halting new clinical trials in Russia while still providing essential medicines to the country. Like others in the sector, it […]

  • Test to Treat: pharmacists say Biden’s major new Covid initiative won’t work

    Program to facilitate access to antivirals will have a limited impact because pharmacists are restricted from prescribing the pills A major new Biden administration initiative to facilitate access to Covid-19 antivirals will have a limited impact and fail to mitigate certain health inequities, major pharmacist groups argue, because pharmacists are restricted from prescribing the pills. […]

  • Hopes raised for once-a-week pills for range of conditions

    Exclusive: Technology developed for new type of contraceptive pill could be applied to other medicines New technology that allows for daily medications to instead be taken just once a week or month could transform the lives of people with conditions ranging from schizophrenia to opioid addiction, researchers have said. The method was initially developed for […]

  • BP and Shell lead rush to exit Russia. There can be no going back

    Oil is always a political business, and there’s no point pretending otherwise First BP, now Shell. The rush to disinvest from Russia is impressively quick since it’s possible to imagine an alternative script in which the oil companies’ boards tried to buy time by issuing woolly “all options are open” statements. A definitive statement to […]

  • GSK boss upbeat over spin-off of consumer healthcare unit

    Expected to be the biggest London listing in a decade, the Haleon demerger is scheduled for July GlaxoSmithKline boss Emma Walmsley said she was “extremely confident” that it would complete the giant spin-off of its consumer healthcare unit in July, despite the market volatility caused by Russia’s invasion of Ukraine. The FTSE 100 company is […]

  • GSK unveils its new consumer brands spin-off name: Haleon

    Products such as Voltaren, Sensodyne and Panadol to regroup under new stock market listing in summer GSK has revealed that its consumer healthcare business, whose brands include Sensodyne toothpaste, Voltaren and Panadol painkillers, will be called Haleon following its planned spinoff and London stock market listing this summer. The drugmaker said Haleon (pronounced “Hay-Lee-On”) was […]

  • Purdue Pharma owners willing to pay up to $6bn to settle opioid suits

    Members of Sackler family would contribute sum over 18 years under latest proposal Members of the Sackler family who own OxyContin maker Purdue Pharma, maker of OxyContin, are willing to kick in more money – up to $6bn in total – to settle thousands of lawsuits over the toll of opioids as the company tries […]

  • Screeching U-turn as Unilever’s shareholders balk at $50bn GSK deal

    Riot in ranks sends ‘strong message’ against tilt at GlaxoSmithKline’s consumer division Unilever’s plan A was to make a huge acquisition; plan B is not to make one, or at least not “for the foreseeable future”. Boardroom U-turns do not come much more screeching. Chief executive Alan Jope referenced a “strong message” from shareholders about […]

  • AstraZeneca forecasts higher 2022 sales and lifts annual dividend

    Drugmaker’s total revenues increased by 41% last year with help from $4bn Covid jab income AstraZeneca forecast higher 2022 sales and lifted its annual dividend for the first time in a decade after beating fourth-quarter profit expectations, but warned the boost from its Covid-19 products would decline. The Anglo-Swedish drugmaker made almost $4bn (£2.9bn) from […]

  • Noisy activists aside, GSK investors backed Walmsley and her strategy

    The ‘step-change’ in growth for the core pharma division has barely started, but the CEO is secure for now Emma Walmsley is at the starting line. That may sound a churlish assessment of years of graft to get GlaxoSmithKline’s consumer products division fit for demerger this summer, but it’s roughly accurate. The “step-change in growth”, […]

  • Boost for GSK as it reports earnings at £1.4bn in Covid-related sales

    Pharmaceutical company’s boss, Emma Walmsley promised a ‘step-change in growth’ after better than expected results GSK made £1.4bn from Covid-related medicines last year, beating earnings forecasts in its first financial results since rejecting Unilever’s £50bn buyout offer in December, as chief executive Emma Walmsley pledged “step-change in growth” in a landmark year. The company is […]

  • Pfizer predicts bumper year from Covid vaccine and pill as profits double

    Drugmaker made $37bn in vaccine sales last year, prompting accusations of profiteering Coronavirus – latest updates See all our coronavirus coverage Pfizer made nearly $37bn (£27bn) in sales from its Covid-19 vaccine last year – making it one of the most lucrative products in history – and has forecast another bumper year in 2022, with […]

  • Johnson & Johnson faces push to force global ban on talc baby powder sales

    Move to hold shareholder vote follows withdrawal of product in US and Canada and lawsuits alleging link to cancer cases The healthcare company Johnson & Johnson is facing an attempt to force a shareholder vote to halt its sales of talc-based baby powder across the world, including the UK, amid concerns over alleged links to […]

  • Djokovic-backed ‘biotech’ firm’s approach likened to homeopathy

    QuantBioRes says it designs treatments for viral diseases based on electromagnetic frequency A Danish “biotech” company in which Novak Djokovic holds a majority stake is working on a “frequency” treatment for Covid-19 that an expert says bears similarities to the principles of homeopathy. The world No 1 men’s tennis player was forced to leave Australia […]

  • Big questions for Unilever board after GSK pursuit ends

    Delivering a minor heart attack to the share price, however temporarily, is not a good look It was fun while it lasted. Unilever says it won’t bump up its £50bn offer for GlaxoSmithKline’s consumer products division, so one has to assume that’s the end of the saga. GSK’s board, after all, can’t credibly have second […]

  • Unilever will not increase £50bn offer for GSK consumer arm

    Company says data shared by GSK suggests ‘fundamental value’ of business no higher than offer Unilever has said it will not increase its offer for GlaxoSmithKline’s consumer healthcare division above £50bn after investors and analysts balked at the risk of it pulling off a large merger. Data shared by GSK suggested the “fundamental value” of […]

  • Djokovic has 80% stake in biotech firm developing Covid drug

    QuantBioRes is working on a treatment not a vaccine, but CEO says tennis star is ‘not anti-vax’ Novak Djokovic is the controlling shareholder in a Danish biotech firm aiming to develop a treatment for Covid-19 that does not involve vaccination, it has emerged. The world No 1, who was deported from Australia this week after […]

  • GSK’s top scientist jumps ship in new blow for pharmaceutical firm

    Hal Barron to leave just as pressure builds on GSK to come up with new medicines Pharmaceuticals company GSK’s chief scientific officer is jumping ship, dealing a blow to the drugmaker as it seeks to rebuild its pipeline of new medicines and gears up for a corporate split in the summer. Hal Barron, the highly-regarded […]

  • Unilever could lose credit rating with purchase of GSK consumer arm

    Deal could swell Unilever’s debt pile says ratings agency Fitch Unilever has been warned that buying GlaxoSmithKline’s consumer products arm is likely to substantially swell its debt pile and could trigger a “multi-notch downgrade” to its credit rating. Ratings agency Fitch said Unilever would not be able to keep hold of its current A rating […]

  • Moderna aims to launch single Covid and flu booster jab within two years

    Combined vaccine should be ready in time for winter infectious season in 2023, says drug firm’s chief executive Moderna is aiming to launch a single booster vaccination that will protect against both Covid-19 and flu within two years, its chief executive has said. Stéphane Bancel said that the combined vaccine – which will protect against […]

  • Unilever to expand health and beauty business after failed GSK approach

    Dove soap maker’s shares are biggest faller on FTSE 100 after offer for consumer products arm is rebuffed Unilever has pledged to grow its health, beauty and hygiene business as investors dumped its shares after its failed £50bn approach for GlaxoSmithKline’s consumer products arm. GSK rejected three Unilever bids for the consumer products arm it […]

  • Analysts say GSK is right to rebuff £50bn offer for consumer healthcare venture

    Unilever’s offer represents only a modest premium to its current value, according to some leading analysts Unilever’s rebuffed £50bn takeover offer for GSK’s consumer healthcare venture, which owns the Panadol and Nicorette brands, represents only a modest premium to its current value, according to some leading analysts, suggesting the drugmaker is right to hold out […]

  • GSK banks on stronger offer for its consumer healthcare business

    Analysis: drugmaker appears to be holding out for what would be one of largest ever deals in London after rejecting Unilever bids With typical bravado, GlaxoSmithKline has, we learned on Saturday, dismissed three takeover bids from Unilever for its consumer healthcare venture with Pfizer, including one worth £50bn received just before Christmas. The drugmaker, run […]

  • Martin Shkreli barred from drug industry and fined $64.6m by US court

    Friday ruling came after FTC and seven states brought a case against Shkreli, nicknamed the ‘Pharma Bro’ Martin Shkreli, the pharmaceutical entrepreneur vilified for astronomically hiking the price of a life-saving drug, has been barred for life from the pharmaceutical industry and fined $64.6m by a US court. The Friday ruling came after the Federal […]

  • Labour peer’s AI healthcare firm Sensyne says cash is running out

    Data analytics company run by Paul Drayson says money could run out in weeks unless it finds emergency funding Shares in Sensyne Health plummeted after the healthcare technology company run by Paul Drayson, the former UK science and defence minister, said it could run out of money within weeks if it was unable to secure […]

  • Wellcome Trust to spend £16bn on research with focus on Covid vaccines

    Britain’s biggest charity announces spending plan over next decade after record return on investments Coronavirus – latest updates See all our coronavirus coverage The Wellcome Trust, Britain’s biggest charity, is ramping up spending on science research to £16bn over the next 10 years, with a focus on funding next-generation Covid-19 vaccines, after it reaped the […]

  • Covid pills are ‘very promising’ – but what are the challenges in using them?

    Paxlovid and molnupiravir were authorized by the US FDA last week, but supplies of Paxlovid are limited while molnupiravir is less effective than hoped An effective and widely available treatment for Covid would be a major breakthrough for managing the pandemic, but two antivirals recently authorized in the US come with some significant caveats, including […]

  • Pfizer/BioNTech tax windfall brings Mainz an early Christmas present

    German city where early Covid vaccine was developed uses its new-found wealth to slash debt and attract other biotech firms The Pfizer/BioNTech jab is having an unexpected side-effect on the German municipality where scientists first developed it: for the first time in three decades the city of Mainz expects to become debt-free thanks to the […]

  • Moderna says booster produces strong antibody response to Omicron

    Pharmaceuticals firm says third dose of its Covid vaccine increases antibodies against variant by 37-fold Coronavirus – latest updates See all our coronavirus coverage The pharmaceuticals company Moderna has said a booster dose of its Covid vaccine appeared to protect against the fast-spreading Omicron variant in laboratory testing and that the current version will continue […]

  • GSK hires ex-Tesco boss Sir Dave Lewis to lead healthcare spin-off

    Glaxo’s consumer healthcare business is to demerge from wider group from mid-2022 The pharmaceutical firm GlaxoSmithKline has hired the former Tesco boss Sir Dave Lewis to chair the consumer healthcare business that it plans to spin off next year. GSK told investors on Monday morning that Lewis, who left Tesco in September last year, would […]

  • UK biotech firm Aptamer to float valued at £80.7m

    York-based company makes synthetic antibodies for pharmaceutical firms including AstraZeneca A British biotechnology firm that supplies big pharmaceutical firms with synthetic antibodies for targeted delivery of drugs will float in London this week valued at £80.7m – giving its two founders a combined paper fortune of more than £33m. Aptamer Group was founded in 2008 […]

  • PCR travel tests need better policing, warns ex-watchdog boss Andrew Tyrie

    Former CMA chair calls for enforcement of at least minimum standards in sector which is becoming ‘a massive rip-off’ Poor service from suppliers of PCR travel tests is “an issue of national significance”, and regulators are not doing enough to police hundreds of new businesses that have moved into the market, the former competition boss […]

  • US sanctions Chinese drugmakers amid addiction epidemic

    Biden administration targets four chemical companies and man said to be world’s leading producer of anabolic steroids The US has imposed sanctions on Chinese painkiller makers – including one man described as the biggest producer of anabolic steroids in the world – as it vowed to step up action to curb the addiction epidemic that […]

  • India’s Poonawalla family donate £50m for Oxford vaccine centre

    Billionaire family own and run world’s largest vaccine producer, Serum Institute of India Coronavirus – latest updates See all our coronavirus coverage The family of the Indian billionaire and self-proclaimed “prince of vaccines” Adar Poonawalla are donating £50m to Oxford University for the construction of a new research centre that will house the team who […]

  • As Covid mutates, the vaccine makers are adapting too

    Focus on the exciting potential of T-cell immunity is spurring the sector on to create a new generation of jabs The speed at which scientists worked to develop the first Covid jabs was unprecedented. Just nine months after the UK went into lockdown, 90-year-old Margaret Keenan officially became the first person in the world outside […]

  • Cancer drug specialist Clinigen agrees to £1.2bn takeover

    Shares soar after board recommends offer from private equity firm Triton Investment Management The cancer drug specialist Clinigen has agreed to a £1.2bn takeover deal from a London-based investment firm, becoming the latest big British company to be taken private. Triton Investment Management has offered to pay 883p a share for the company, whose main […]

  • ‘Wall of secrecy’ in Pfizer contracts as company accused of profiteering

    US company faces scrutiny over Covid profits after UK agrees to secrecy clause Coronavirus – latest updates See all our coronavirus coverage Ministers have agreed a secrecy clause in any dispute with the drugs manufacturer Pfizer over Britain’s Covid vaccine supply. Large portions of the government’s contracts with the company over the supply of 189m […]

  • US author to give away £10,000 prize cash over role of sponsor in opioid crisis

    Investigative reporter Patrick Radden Keefe will give money from business book of the year shortlisting to charity over involvement of McKinsey firm The American writer Patrick Radden Keefe has said he will give away the £10,000 he was awarded by a book prize whose sponsor helped to sell the opioid painkiller OxyContin. Radden Keefe’s damning […]

  • Covid: scientists find possible trigger for AstraZeneca jab blood clots

    Experts hope better understanding of rare side effect of vaccine could help ‘turn the tide’ on pandemic Coronavirus – latest updates See all our coronavirus coverage Scientists believe they may have found the trigger behind the extremely rare blood clot complications stemming from the Oxford/AstraZeneca’s Covid vaccine. According to a team of researchers from Cardiff […]

  • Teesside factory making Covid vaccine gets £400m injection

    Japanese owner makes single biggest investment in UK pharmaceutical manufacturing in decades A Teesside factory that makes Covid-19 vaccines has received a £400m injection from its Japanese owners, the largest single investment in UK pharmaceutical manufacturing in decades. The biotechnology arm of the Japanese conglomerate Fujifilm, which is better known for its photography heritage, said […]

  • Moderna boss predicts current vaccines may be less effective against Omicron covid

    Stock markets dip as CEO says firms may struggle in targeting both new strain and existing Covid variants The chief executive of the US drugmaker Moderna has predicted that existing vaccines will be less effective against Omicron than they have been against the Delta version, sending global stock markets sharply lower. Stéphane Bancel said while […]

  • The Omicron variant reveals the true global danger of ‘vaccine apartheid’

    Sharing vaccines with poorer countries is the right thing and the self-interested thing to do. The west needs to stop being so short-sighted Mandatory face masks are back in England. The fear factor has returned. After months of assuming the Covid-19 pandemic was all but over, the UK government has imposed new restrictions in an […]

  • ‘Follow the science’: AstraZeneca unveils £1bn R&D centre

    Anglo-Swedish pharmaceutical company has come a long way since it fought off a takeover bid in 2014 Little expense has been spared at the giant glass and steel structure that sprouts from a once-vacant plot of land on the outskirts of Cambridge. AstraZeneca’s £1bn new research and development centre houses 16 labs and 2,200 scientists, […]

  • Poorer nations still lack access to world’s key antibiotics

    Only 54 of 166 assessed treatments have policies aiding use by low-income countries, says non-profit group The world’s biggest drugs makers have pressed on in the fight against superbugs despite the pandemic, but millions of people in poorer countries, where the risk of drug-resistant infections is highest, are still missing out on key antibiotics. A […]

  • UK firm to trial T-cell Covid vaccine that could give longer immunity

    Exclusive: Oxfordshire-based Emergex gets go-ahead for trials in Switzerland for skin patch vaccine Coronavirus – latest updates See all our coronavirus coverage An Oxfordshire-based company will soon start clinical trials of a second-generation vaccine against Covid-19, an easy-to-administer skin patch that uses T-cells to kill infected cells and could offer longer-lasting immunity than current vaccines. […]

  • Johnson & Johnson to spin off consumer arm to focus on medical division

    Shake-up is the biggest in healthcare company’s 135-year history and follows similar moves by rivals Healthcare giant Johnson & Johnson is to spin off its consumer arm, known for its Band-Aid plasters, baby shampoo and Listerine mouthwash, to focus on developing medicines and medical devices. The New Jersey-headquartered firm, which employs 136,000 people worldwide, said […]

  • AstraZeneca sells $2.2bn of Covid vaccine in first nine months

    Drugmaker says it expects to transition to ‘modest profitability’ as it receives new orders Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has sold more than $2.2bn (£1.64bn) of its Covid-19 vaccine in the first nine months of this year, as the drugmaker said it is set to move to “modest profitability” as […]

  • AstraZeneca to create dedicated Covid vaccines unit

    Move intended to make it easier to continue producing coronavirus shot over the long term Coronavirus – latest updates See all our coronavirus coverage AstraZeneca is to create a new vaccines unit as the Anglo-Swedish drugmaker plans for the future of its coronavirus shot beyond the pandemic. The company said the reorganisation would bring together […]

  • Pfizer raises Covid-19 vaccine sales forecast to $36bn for 2021

    US drugmaker expects to manufacture 3bn doses of vaccine with BioNTech this year Coronavirus – latest updates See all our coronavirus coverage The US drugmaker Pfizer has lifted its 2021 forecast for revenues from its Covid vaccine to $36bn (£26.3bn), after bumper sales in the third quarter. The Covid jab, called Comirnaty and developed with […]

  • Post-lockdown colds spur sales at Strepsils and Nurofen maker

    Reckitt Benckiser records better than expected results after rise in cases of coughs and flu Reckitt Benckiser enjoyed better than expected results thanks to demand for its treatments for coughs, colds and flu, following a rise in cases after the lifting of global lockdowns. The Berkshire-based consumer goods company recorded a “sharp improvement” in demand […]

  • Walmsley needs a fast-acting remedy for GSK’s malaise

    With just a few years to turn the group around, the boss could do without a bellicose hedge fund breathing down her neck Few companies fit with the national zeitgeist quite like drugs giant GlaxoSmithKline. But few face the cocktail of pressures Dame Emma Walmsley, chief executive at Britain’s second-biggest drugmaker, is wrestling with. In […]

  • Local Covid vaccines fill gap as UN Covax scheme misses target

    India, Egypt and Cuba among first states to develop and make their own vaccines as Covax falls behind Developing countries are increasingly turning to homegrown Covid vaccinations as the UN-backed Covax programme falls behind. While western countries roll out booster jabs to their own populations, Covax, which was set up by UN agencies, governments and […]

  • UK drugmaker GSK under fresh pressure to sell consumer arm

    Hedge fund Bluebell also demands replacement of GlaxoSmithKline chairman Sir Jonathan Symonds The British drugmaker GlaxoSmithKline has come under fresh pressure to sell off its consumer arm and carry out a change of leadership, with a hedge fund demanding the appointment of a new chairman. Bluebell Capital Partners, an activist London-based hedge fund that has […]

  • How do I finance my root canal treatment?

    Uh oh, you have a toothache. You make your way over to the dentist that you haven’t visited since 2018, but it turns out that your insurance plan expired. And you need a root canal. Before seeing the endodontist, you want to get a general idea of how much it costs and how you’re going […]

  • WHO endorses use of world’s first malaria vaccine in Africa

    World Health Organization’s director general hails ‘historic day’ in fight against parasitic disease The World Health Organization has recommended the widespread rollout of the first malaria vaccine, in a move experts hope could save tens of thousands of children’s lives each year across Africa. Hailing “an historic day”, the WHO’s director general, Dr Tedros Adhanom […]

  • Coronavirus treatments: the potential ‘game-changers’ in development

    After positive clinical trials for antiviral drug Molnupiravir, it joins other medicines that have shown promise Coronavirus – latest updates See all our coronavirus coverage The first clinical trial results showing a positive effect for a pill that can be taken at home has been hailed as a potential gamechanger that could provide a new […]

  • Welsh scientist makes potential $539m fortune from biotech flotation in US

    Value of Andrew Hopkins’ Exscientia firm reaches market value of $2.9bn in Nasdaq IPO A Welsh scientist who dreamed up his artificial intelligence biotech company while walking home from the laboratory is sitting on a potential $539m (£400m) paper fortune after its $2.9bn stock market float. The idea for Exscientia, an Oxford-based firm that uses […]

  • Covid antiviral pill halves hospitalisations and deaths, maker says

    If approved, Merck’s drug would be first simple oral medication shown to be effective against coronavirus Coronavirus – latest updates See all our coronavirus coverage The first pill to treat coronavirus could be available within months after it was found to cut hospitalisations and deaths by half. If approved, the antiviral drug would be the […]

  • UK pharmacies in dark about ministers’ plan to maintain drug supplies

    Chemists wait for details of measures to ensure driver shortages do not adversely affect deliveries of prescription drugs Pharmacists are waiting for details from the government about what measures are in place to deal with any delays to deliveries of drug supplies as a result of van driver shortages. If the situation worsens, pharmacists have […]

  • Second hedge fund pushes for change in leadership of GSK

    Bluebell Capital takes stake in pharma giant and puts pressure on Emma Walmsley GSK’s chief executive, Emma Walmsley, has come under pressure from a second activist hedge fund, Bluebell Capital Partners, which has taken a stake in the drugmaker to push for change at the top, including forcing her to reapply for her job. The […]

  • Big pharma fuelling human rights crisis over Covid vaccine inequity – Amnesty

    Six companies warned not to put profit before lives as report shows less than 1% of almost 6bn doses have gone to low-income countries Amnesty International has accused six pharmaceutical companies that have developed Covid-19 vaccines of fuelling a global human rights crisis, citing their refusal to sufficiently waive intellectual property rights, share vaccine technology […]

  • GSK teams with King’s College to use AI to fight cancer

    Artificial intelligence will be used to develop personalised treatments while investigating role of genetics The pharmaceuticals firm GSK has struck a five-year partnership with King’s College London to use artificial intelligence to develop personalised treatments for cancer by investigating the role played by genetics in the disease. The tie-up, which involves 10 of the drug […]

  • UK cancels Covid vaccine deal with French firm Valneva

    Government serves notice to terminate contract over allegations of a ‘breach of obligations’ Coronavirus – latest updates See all our coronavirus coverage The UK government is to pull out of a deal with the French pharmaceutical company Valneva to purchase its Covid-19 vaccination, the company has said. The move will come as a blow to […]

  • A year that changed the world – and medical companies’ fortunes

    While Covid sent many firms to the wall, others prospered by spotting opportunities, from test kits to mask coatings The pandemic has taken a heavy toll on business, gutting high streets as familiar names fell into receivership. But for some less well-known firms, the past 18 months have been transformational. Those that have thrived did […]

  • BioNTech to seek approval for Covid jabs for younger children

    Company behind Pfizer vaccine expected to file results of trial of five- to 11-year-olds with regulator soon Coronavirus – latest updates See all our coronavirus coverage The German company BioNTech, which developed the Pfizer vaccine, expects to seek approval from regulators for Covid jabs suited for younger children as early as mid-October, its founders have […]

  • Japan’s Moderna Covid vaccine rollout hit by recall and contamination scares

    Foreign materials including stainless steel identified in batches of Covid-19 vaccine though no safety or efficacy issues have been reported The Moderna coronavirus vaccine programme in Japan has been hit by a series of contamination incidents, prompting it to recall 1.63m doses found to contain metal fragments. Other potential contaminants have been identified in separate […]

  • Major shareholder’s Rolls-Royce grumble could rumble on

    Vague demand for board refresh from Causeway likely a hangover from £2bn rights issue The last time Rolls-Royce had an US activist fund on its tail, the aero-engine manufacturer took the unusual step of inviting one of its representatives onto the board. ValueAct Capital was judged to have constructive ideas and useful industry expertise. The […]

  • Why Dental Financing is Important

    In 2016, the American Dental Association reported that dental care has the highest cost barrier in comparison to other healthcare services. The cost barrier for dental care prevents most patients from getting the proper care they need. Oral health can easily be neglected and labelled as unimportant, but that’s certainly not the case. In fact, […]

  • Boots launches on-demand delivery trial with Deliveroo

    Customers can order medicines for mild ailments, makeup, toiletries and more from 14 stores The pharmacy chain Boots will become the latest large retailer to make its products available through Deliveroo, as the takeaway delivery company aims to expand beyond restaurant orders. Stores in London, Birmingham, Edinburgh and Nottingham will be among the 14 initially […]

  • UK approves rollout of ‘first of its kind’ Covid antibody treatment

    Ronapreve can be used to treat symptoms of acute infection after successful clinical trials Coronavirus – latest updates See all our coronavirus coverage The medicines regulator has approved use of the first treatment in the UK using artificial antibodies to prevent and fight Covid-19. The health secretary, Sajid Javid, said approval of the first drug […]

  • Drug firms poised to make billions of dollars from Covid booster jabs

    Sales of BioNTech, Moderna and Pfizer drugs could rival $6bn-a-year market for flu vaccines, say analysts Coronavirus – latest updates See all our coronavirus coverage The drug companies Pfizer, BioNTech and Moderna are poised to make billions of dollars from Covid-19 booster jabs this autumn, with analysts estimating that sales could rival the $6bn-a-year market […]

  • Covid-19 vaccines: the contracts, prices and profits

    Raised charges and Covax deals on order books of Pfizer, BioNTech, Moderna and AstraZeneca Coronavirus – latest updates See all our coronavirus coverage Two US companies, Pfizer and Moderna, have raised the prices of their Covid-19 vaccines after data from clinical trials showed their mRNA formula was more effective than cheaper vaccines from Britain’s AstraZeneca […]

  • UK could allow animal tests for cosmetic ingredients for first time since 1998

    Exclusive: campaigners say aligning with EU ruling on chemical testing will ‘blow a hole’ in UK leadership on cruelty-free cosmetics Ministers have opened the door to expanding the use of animal testing to ingredients used in cosmetic products for the first time in 23 years, an animal welfare charity has said. Cruelty Free International (CFI) […]

  • Carlyle ups bid for inhaler firm Vectura, trumping tobacco giant Philip Morris

    Offer for UK company from Marlboro cigarettes maker had alarmed medical experts US private equity firm Carlyle has made an improved £958m takeover offer for British inhaler maker Vectura, trumping an earlier bid from tobacco company Philip Morris International that had alarmed medical experts. Carlyle said on Friday it would offer 155p a share for […]

  • Pfizer and Flynn accused of overcharging NHS for anti-epilepsy drugs

    Competition regulator the CMA alleges drugs firms abused dominant position with unfairly high prices Pharmaceutical companies Pfizer and Flynn have been accused by the UK’s competition watchdog of illegally overcharging the NHS for vital anti-epilepsy drugs by abusing their dominance in the market to raise prices overnight. The Competition and Markets Authority (CMA) has confirmed […]

  • As Delta spreads, Pfizer and Moderna get set for a booster shot to profits

    The firms are already taking the lion’s share of earnings from the market, as this week’s results will show Praised for preventing hundreds of thousands of deaths and allowing a return to more normal life, Covid vaccines will also substantially benefit some pharmaceutical companies. In June, analysts estimated the global market for the vaccines could […]

  • Drug firm that hiked prices by 6,000% paid shareholders £400m

    Advanz Pharma and former private equity owners were fined £100m by markets watchdog A pharmaceuticals firm that inflated thyroid drug prices by up to 6,000% over a decade paid out more than £400m to shareholders and directors during the same period. London-based Advanz Pharma – and its former private equity owners HgCapital and Cinven – […]

  • What Credit Score Is Needed For Dental Financing?

    Many Americans already have dental anxiety for obvious reasons, but another factor to consider is the cost. According to research findings from the Agency for Healthcare Research and Quality, the average annual expense for a dental visit has increased by 86% since 1996, and continues to increase as time progresses. This leaves many people at […]

  • Pain aggravation: the human cost of medicine price hikes

    After Advanz’s £100m fine over the price of its thyroid tablets, two people recount the difficulty of obtaining medication The UK’s competition watchdog has fined pharmaceutical company Advanz over £100m for inflating the price of its thyroid tablets by up to 6,000%. The exorbitant costs resulted in NHS clinical commissioning groups advising doctors not to […]

  • AstraZeneca sales of Covid vaccine triple to $1.2bn in first half of 2021

    Not-for-profit pledge sees British firm’s sales revenue fall significantly short of US rival Pfizer Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s Covid-19 vaccine has brought in $1.2bn (£900m) in the first half of this year, with sales tripling in the second quarter from the first – but its earnings remained significantly below […]

  • Pharma firm Advanz fined after thyroid drug price hike of 6,000%

    CMA found company’s ‘excessive and unfair’ prices cost NHS almost £30m extra over 10 years The UK’s competition watchdog has imposed fines of more than £100m on the pharmaceutical company Advanz and its former private equity owners after it was found to have inflated the price of its thyroid tablets by up to 6,000%. An […]

  • Why Dentists Offer Payment Plans

    Visiting the dentist can be frightening. Sure, having a cavity filled or a tooth pulled is scary in itself, but the true scare tends to come at the end: the dental bill.  While insurance may help offset costs, most annual plans max out somewhere between $1,000 to $2,000, leaving you to still pay for the […]

  • How Do I Get Customers To Stop Leaving My Site?

    The tendency of many business owners is to do everything themselves. There are too many things that you need to do to focus on perfecting every single one of them on your own. For this reason, many businesses turn to other perfected products and services and form an agreement or partnership to use that product […]

  • GSK plans £400m life sciences campus in Stevenage

    Pharmaceuticals firm thinks creating cluster of companies at its site could result in up to 5,000 jobs GlaxoSmithKline is seeking to create a £400m campus in Stevenage for new life sciences companies that it believes could result in up to 5,000 jobs over the next decade. The pharmaceuticals company has kicked off a process to […]

  • UK drug companies fined £260m for inflating prices for NHS

    Watchdog issues warning after abuses that included paying would-be rivals to stay out of the market The UK’s competition watchdog has imposed fines totalling more than £260m on pharmaceutical companies after an investigation found that they overcharged the NHS for hydrocortisone tablets for almost a decade. The Competition and Markets Authority (CMA) found that the […]

  • Pfizer pushes for booster shots as WHO says greed is driving vaccine disparities

    • Pharmaceutical company seeks FDA approval for third dose • Companies urged to instead prioritise less wealthy countries After a sharp increase in US Covid cases and amid fears of a surge of the Delta variant, Pfizer on Monday said it was seeking federal authorisation for third doses of its Covid-19 vaccine to be delivered […]

  • FDA calls for investigation into its contacts with Alzheimer’s drug maker

    • Acting commissioner refers agency to inspector general • Biogen Inc’s drug Aduhelm controversially approved last month The US drug regulator has called for an independent federal investigation into the interactions between its representatives and Biogen Inc that led to the approval of the company’s Alzheimer’s disease drug last month. The drugmaker’s shares fell 3% […]

  • Philip Morris International makes £1bn offer for pharma firm Vectura

    Tobacco company strikes deal for British firm developing pioneering inhaled treatment for Covid-19 Coronavirus – latest updates See all our coronavirus coverage Philip Morris International, the tobacco company and maker of Marlboro cigarettes, has struck a £1bn deal to buy Vectura, the British pharmaceutical company developing a pioneering inhaled treatment for Covid-19. The £1.04bn offer […]

  • Oxford drugs firm gains $1.5m Gates grant for Covid-19 therapy

    Exclusive: Exscientia to use AI in proposed fast-track development of ‘low-cost’ pill for Sars viruses Coronavirus – latest updates See all our coronavirus coverage Exscientia, an Oxford-based firm that uses artificial intelligence to develop medicines, has won a $1.5m grant from the Bill & Melinda Gates Foundation to create a Covid-19 treatment that also works […]

  • GSK firmly rejects Elliott Management’s demands over chief executive

    Hedge fund had sought to force Emma Walmsley to reapply for her job ahead of drugmaker’s corporate split The drugmaker GlaxoSmithKline has issued a firm rejection of the main demands made by the activist investor Elliott Management, and insisted its chief executive, Emma Walmsley, would lead the new pharmaceuticals and vaccines company after a corporate […]

  • Activist investor Elliott tries to force GSK boss to reapply for her job

    US hedge fund ratchets up pressure on Dame Emma Walmsley before company’s demerger next year The US activist investor Elliott Management has in effect demanded Dame Emma Walmsley reapply for her job as chief executive of GlaxoSmithKline before the pharmaceutical company’s demerger of its consumer healthcare division next year. In a 17-page public letter (pdf) […]

  • Drug firms giving MPs ‘hidden’ funding, research shows

    Pharmaceutical industry has “hidden web of policy influence” over dozens of all-party parliamentary groups Drug companies are giving groups of MPs and peers that campaign on health issues hundreds of thousands of pounds a year in “hidden” funding that could hand them “undue influence”, research has found. The pharmaceutical industry has built up a “hidden […]

  • GSK’s changes leave a long road ahead but CEO Walmsley deserves a hearing

    Emma Walmsley still has time to build belief in product pipeline – but clinging onto consumer division hardly shouts confidence “I am a change agent,” declared Emma Walmsley, as she unveiled the biggest overhaul of GlaxoSmithKline in the 20-odd years of the company’s life in its current form. The consumer healthcare division will depart via […]

  • GSK drugmaker sets ambitious sales target before shake-up

    Firm aims to boost pharmaceutical and vaccine business by 5% annually for five years GSK has cut its dividend and set ambitious sales targets as its under-pressure chief executive, Dame Emma Walmsley, pledged to lead Britain’s second-biggest drugmaker through a corporate shake-up next year. GSK is spinning off its consumer healthcare business and aims to […]

  • How much does a dental implant cost?

    A study by the American College of Prosthodontics revealed that over 36 million people in the United States don’t have any teeth, while 120 million are missing at least one tooth. This is often the result of accidents, cavities, gum disease, teeth misalignment, and other factors. To resolve this issue, many have used dental bridges […]

  • Western countries must share Covid vaccines – if only for the sake of their GDP

    Optimistic forecasts about ‘bouncing back’ will only come true if new variants do not close borders and devastate trade again Coronavirus – latest updates See all our coronavirus coverage The world economy is on course to bounce back from the pandemic with a momentum that will carry through to next year and beyond. This prediction, […]

  • Will Emma Walmsley’s radical therapy cure GlaxoSmithKline?

    The boss’s plan to divide the pharma giant has support – but her own position may hinge on a crucial presentation this week Dame Emma Walmsley faces the toughest day of her career as chief executive of GlaxoSmithKline on Wednesday. The head of Britain’s second-biggest drugmaker will present a 10-year outlook to shareholders and analysts, […]

  • Covid jabs for billions of humans will earn their makers billions of dollars

    We look at the drug firms – led by Pfizer and Moderna – that are set to profit most in an unprecedented global vaccination drive Coronavirus – latest updates See all our coronavirus coverage Drugmakers led by US firms Pfizer and Moderna stand to make tens of billions of dollars from their Covid-19 vaccines this […]

  • EU fails in court action to secure urgent 120m doses of Oxford Covid vaccine

    But Brussels court says AstraZeneca should earlier have used UK plants to fulfil EU deliveries Coronavirus – latest updates See all our coronavirus coverage The EU has failed in a legal attempt to secure an urgent 120m vaccine doses from AstraZeneca by the end of this month, while securing a judgment that sites in Oxford […]

  • EU fails in court action to secure urgent 120m doses of Oxford Covid vaccine

    But Brussels court says AstraZeneca should earlier have used UK plants to fulfil EU deliveries Coronavirus – latest updates See all our coronavirus coverage The EU has failed in a legal attempt to secure an urgent 120m vaccine doses from AstraZeneca by the end of this month, while securing a judgment that sites in Oxford […]

  • AstraZeneca vaccine price pledge omits some poor countries, contract shows

    Exclusive: firm could charge more in places such as Zimbabwe and Sri Lanka once Covid pandemic is over Coronavirus – latest updates See all our coronavirus coverage AstraZeneca can charge a higher price for its Covid-19 vaccine in dozens of poor countries once the pharmaceutical company decides the pandemic has ended, according to a copy […]

  • Vaccines were not part of AstraZeneca’s grand strategy, so what’s the plan now?

    Having built a big operation during the pandemic it could stick or twist but either way investors will soon want a decision What’s AstraZeneca’s strategy in Covid treatments? In the short term, there is no confusion: the company will continue pumping out vaccine doses, will keep signing partnerships and will try to ignore churlishness in […]

  • Hospitality firms urgently need clarity from Sunak about £2.5bn of unpaid rent

    Giving landlords and tenants six months to work out a deal on arrears could stop an wave of bankruptcies in the sector If it really is a case of “one more heave” on vaccinations before restrictions on the hospitality sector can be eased, what’s the best way to ensure the country’s pubs, restaurants and nightclubs […]

  • Covid vaccine programme for developing countries could cost $6.5bn

    If pharmaceutical companies do not waive intellectual property rights the cost could reach $80bn Coronavirus – latest updates See all our coronavirus coverage The world’s developing countries could be vaccinated against Covid-19 at a cost of just $6.5bn (£4.6n) if pharmaceutical companies waive their intellectual property rights, under plans being outlined at the G7 summit […]

  • US drugmaker Regeneron under fire for ‘excessive’ payouts to executives

    Advisory groups questioned whether the upfront payouts were in the best interests of shareholders The US drugmaker Regeneron, whose Covid treatment was hailed as a “cure” by Donald Trump last year, has come under fire from two influential shareholder advisory groups over “excessive” payouts made to its top executives ahead of its annual meeting on […]

  • Ronald Cresswell obituary

    Pharmaceutical researcher with a flair for business who brought a string of vital drugs to market In 1960 the chemist Ronald Cresswell, who has died aged 86, had a lucky break. As a result of travelling from Glasgow to take up a post in New York he attended a conference of the American Chemical Society, […]

  • More research funding needed to avoid drug-resistant pandemic, warns report

    Smaller firms are developing most antibiotics targeting superbugs but often at risk of bankruptcy Small drugmakers and biotech firms that are developing the bulk of new antibiotics need far more financial support, according to a new report, which warned that without these life-saving medicines there could be a pandemic of drug-resistant infections, worse than Covid-19. […]

  • Taiwan accuses China of interfering with Covid vaccine deals

    President says agreement with German firm BioNTech has been delayed after Beijing intervention Coronavirus – latest updates See all our coronavirus coverage Taiwan’s president has accused China of interfering in its vaccine acquisition programme, as the island continues to battle hundreds of daily new cases of Covid-19 with low supplies of vaccines. Taiwan has received […]

  • Has Marks and Spencer really got it right at last? | Nils Pratley

    We’ve heard the argument before, but now it does seem the moment of maximum danger has passed Green shoots at M&S? That was chairman Archie Norman’s boast as he peered through the thicket of exceptional charges that dominated yet another set of annual results and turned a small headline pre-tax profit of £41.6m into a […]

  • UK pharmaceutical firm Ventura agrees to £958m takeover deal

    Private equity firm Carlyle Group to buy company that is developing inhaled treatment for Covid-19 Coronavirus – latest updates See all our coronavirus coverage The British pharmaceutical company Vectura Group, which is developing a pioneering inhaled treatment for Covid-19, has agreed a £958m takeover by Carlyle Group as it looks set to become the latest […]

  • How Much Does A Surgical & Non-Surgical Nose Job Cost With Or Without Insurance?

    Whether you injured your nose, have breathing issues, or a birth defect, there are many reasons why one would choose to get a nose job (or in surgical terms, rhinoplasty). Surgical and non surgical rhinoplasty can both alter the appearance of the nose, but beyond this initial similarity, the route by which cosmetic surgeons go […]

  • Labour says UK must ‘get off the fence’ over global Covid vaccine access

    Shadow trade secretary backs US call for patent waiver as party proposes plan to increase production in poorer countries Coronavirus – latest updates See all our coronavirus coverage The Labour party is urging Boris Johnson to lead a drive by rich countries to boost global Covid-19 vaccine production and is warning the threat from new […]

  • GSK and Medicago report positive Covid vaccine trial data

    Announcement follows encouraging news from collaboration with French drugmaker Sanofi Coronavirus – latest updates See all our coronavirus coverage GlaxoSmithKline has unveiled positive interim results from mid-stage trials of a Covid-19 vaccine it is developing with the Canadian biotech firm Medicago, a day after releasing strong data from its vaccine collaboration with the French drugmaker […]

  • GlaxoSmithKline and Sanofi report strong results in trials of Covid vaccine

    News will offer some some relief for GSK chief Emma Walmsley, who has been under pressure from investor GlaxoSmithKline is in the running to bring a new Covid-19 vaccine on to the market by the year end, thanks to positive results from early trials that will allow the formula to enter into late-stage studies within […]

  • We’re all the poorer for shareholders’ loss of nerve on executive pay

    AstraZeneca’s vaccine effort is remarkable, but investors should not have let it divert them from the job of moderating bonuses Investors failed another test of backbone last week, as a number of eye-popping pay packages overcame the threat of voter rebellions at annual general meetings. The board of AstraZeneca asked shareholders to support their decision […]

  • Nearly 40% of AstraZeneca investors reject boss’s bonus rise

    Covid vaccine maker passes its remuneration policy but suffers sizeable rebellion AstraZeneca investors narrowly approved pay package proposals for its chief executive, Pascal Soriot, after nearly 40%voted against the policy, which could hand him payand perks of up to £17.8m for 2021. At the company’s annual meeting in Cambridge, the Anglo-Swedish drugmaker managed to pass […]

  • AstraZeneca chief executive’s pay rise in doubt ahead of investor vote

    Investors are lining up to oppose pay-and-perks plan for Pascal Soriot worth up to £17.8m for 2021 AstraZeneca could be forced to rip up plans to boost the pay of its chief executive, Pascal Soriot, as investors prepare to vote on proposals that could take his remuneration after nearly a decade at the helm of […]

  • How US companies could use patients’ data from Covid vaccine drive

    Privacy advocates warn retail pharmacies in particular are blurring the line between public health and commerce Data rights organizations have warned that patients lack a clear understanding of how information about their health, employment, contact or location details may be used if it is collected by private entities during the Covid-19 vaccine drive. Some advocates […]

  • Pharmaceutical firms’ shares tumble after US plans patent waiver on Covid vaccines

    Shares in Chinese and US companies fell sharply following announcement to boost production Coronavirus – latest updates See all our coronavirus coverage Shares in pharmaceutical companies fell sharply after the US government threw its weight behind global plans for a patent waiver on Covid-19 vaccines to boost their production and distribution around the world. Shortly […]

  • EU wants to mass produce three ‘course-changing’ Covid drugs from October

    Health commissioner says plan is to reduce hospitalisation and tackle long-term impact of Covid Coronavirus – latest updates See all our coronavirus coverage Three Covid medicines with the potential to “change the course” of the pandemic will be authorised for mass production and use in the EU by October under a European Commission plan. Stella […]

  • US support for Covid vaccine patent waivers puts pressure on EU and UK

    Analysis: Joe Biden’s support for idea is vital but it won’t happen without backing of other rich nations Coronavirus – latest updates See all our coronavirus coverage It was a “seismic decision” by Joe Biden, the US president, say campaigners who have fought for the demolition of patent protection on vaccines and drugs for decades. […]

  • Indivior’s UK shareholders have chance to put teeth into clawback clauses | Nils Pratley

    Former chief executive sent to prison for six months but will keep $1.65m in outstanding pay awards “We recognise that our remuneration structure is different in some respects from a typical UK package,” said Daniel Phelan, the chair of Indivior’s remuneration committee, in the company’s annual report. You bet. The difference isn’t only the size […]

  • Indivior faces shareholder revolt over ex-chief’s bonus

    Shaun Thaxter was sentenced to six months in US prison for his role over drug misinformation case Indivior faces the threat of a shareholder revolt over the drugmaker’s decision to maintain bonus payments for its British former chief executive, who was jailed last year in a case related to the US opioid crisis. Continue reading…

  • Sunak’s stamp duty holiday extension has merely inflamed the housing market

    Throwing money at an already heated market looks nonsensical and could lose the Treasury £2bn Surprise, surprise. Presented, or so they thought, with an end-March deadline to save a few thousand pounds on stamp duty, buyers rushed to complete their house purchases. Mortgage lending in the month reached a new record. It requires no imagination […]

  • ‘Obscene’ bonus hike for AstraZeneca boss prompts investor anger

    Advisory groups ask shareholders to oppose bid to raise Pascal Soriot’s maximum share bonus to 650% of £1.3m basic pay AstraZeneca is facing mounting opposition over its plans to award its chief executive, Pascal Soriot, a big increase in bonuses, with two investor advisory groups calling on shareholders to vote against the policy. Glass Lewis […]

  • Pfizer forecasts $26bn from annual sales of Covid-19 vaccine

    Vaccine will generate 73% more than forecast based on contracts signed until mid-April Coronavirus – latest updates See all our coronavirus coverage US drugmaker Pfizer expects to make $26bn (£19bn) in revenues from sales of its Covid-19 vaccine this year, with its soaraway product accounting for more than a third of the company’s annual income. […]

  • Investors flock to life sciences as UK sector breaks funding record

    Covid crisis spurs growing interest in drugmakers, diagnostics and medical equipment firms UK drugmakers, diagnostics, medical equipment and other life sciences companies have raised £10.6bn from private funding rounds and stock market flotations in the first three months of the year, more than half of last year’s record total, according to a report. Last year, […]

  • AstraZeneca revenues up as it delivers jab to 120 countries via Covax

    Quarterly results from Anglo-Swedish producer of Covid vaccine show better-than-expected 15% rise Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has generated $275m (£197m) in revenues from its Covid vaccine in the first three months of the year and shipped 48m doses to 120 countries through the global vaccine-sharing initiative Covax. Most of […]

  • Miracles may not be in the pipeline at GSK but it’s too soon to panic | Nils Pratley

    The CEO’s best policy is to ignore the noise. The decluttering demerger plan looks solid and is backed by shareholders It was not a knockout quarter to put Elliott Management, the big, aggressive and newly arrived US activist hedge fund, back in its box. GlaxoSmithKline’s revenues fell 18% as patients, sensibly, delayed their GSK shingles […]

  • GSK’s Emma Walmsley vows to lead drugs firm through corporate split

    CEO is under pressure to improve GSK’s performance after profit slump and arrival of activist shareholder GlaxoSmithKline’s chief executive, Emma Walmsley, has vowed to lead the company through next year’s corporate split and beyond, and to keep research spending high, as she came under mounting pressure to improve the drugmaker’s performance after a decline in […]

  • Emergent chief sold $10m in stock before company ruined 15m Covid vaccines

    Stock unloaded by Robert G Kramer would now be worth only $5.5m while FDA report found unsanitary conditions at plant Coronavirus – live news The chief executive of the pharmaceutical giant Emergent BioSolutions sold $10m in company stock weeks before the publication of the company’s financial results and a production error that ruined 15m Covid-19 […]

  • EU starts legal action against AstraZeneca over vaccine shortfalls

    Firm says it will ‘strongly defend itself’ against claim it breached agreement to supply Covid jab Coronavirus – latest updates See all our coronavirus coverage AstraZeneca said it would “strongly defend itself in court” and highlighted its supply of 50m Covid vaccine doses to European countries as Brussels launched legal action against the pharmaceutical company […]

  • GlaxoSmithKline faces dose of strong medicine from US investor

    This week’s lacklustre results will strengthen boss Emma Walmsley’s case for reform – but also inspire her critics When the American hedge fund Elliott Management took a sizeable stake in GlaxoSmithKline this month, the drugmaker’s shares jumped 5% on speculation of a possible shake-up at the company. GSK’s chief executive, Emma Walmsley, will face questions […]

  • EU’s legal pursuit of AstraZeneca looks short-sighted

    Only semi-guaranteed outcome is that big pharma will never again agree to work for no profit during a pandemic It’s been hard to keep up with the European commission and EU leaders’ changing stances on the Oxford/AstraZeneca coronavirus vaccine. But the ferocity of complaints about delayed deliveries seemed to have lessened in recent weeks. When […]

  • Revealed: big shortfall in Covax Covid vaccine-sharing scheme

    Only a fifth of doses expected by May delivered as export bans, hoarding and supply shortages bite Coronavirus – latest updates See all our coronavirus coverage The global vaccine-sharing initiative Covax has so far delivered about one in five of the Oxford/AstraZeneca doses it estimated would arrive in countries by May, according to a Guardian […]

  • The Covid crisis: some people think it’s all over … it isn’t

    A new reality check is coming unless the west replicates its ‘whatever-it-takes approach’ to help poorer countries cope Denial. Panic. False dawn. Relief mingled with a decent dollop of euphoria. Britain’s response to Covid-19 has moved through distinct phases, and there are at least two more to come. Despite the success of the vaccine programme, […]

  • How can small businesses stand out against large corporations?

    It can be challenging for businesses to stand out among the competition, especially when the competitors are multi million-dollar corporations.  A Public Affairs Pulse survey polling What Americans Think About Business showed that 69 percent of respondents had a favorable opinion of large businesses, but far greater than that was the rating given to small […]

  • GlaxoSmithKline shares jump at news of activist hedge fund interest

    UK pharmaceutical company has been under pressure to rebuild portfolio of new medicines Shares in GlaxoSmithKline jumped on Thursday, after it emerged that the activist hedge fund Elliott Management has built a sizeable stake in the company, signalling a potential battle over the future of the UK drug maker. New York-based Elliott, which is run […]

  • EU seeking ‘urgent clarification’ on Johnson & Johnson Covid vaccine delay

    Company has said it is postponing deployment in Europe following concerns about blood clots in US Coronavirus – latest updates See all our coronavirus coverage The European commission is seeking “urgent clarification” from Johnson & Johnson after the company’s “completely unexpected” announcement that it has decided to delay the deployment of its coronavirus vaccine across […]

  • Global Covid vaccine rollout threatened by shortage of vital components

    Pharmaceutical firms warn of delays to items such as the large bags in which vaccine cells are grown Coronavirus – latest updates See all our coronavirus coverage Vaccine-makers around the world face shortages of vital components including large plastic growbags, according to the head of the firm that is manufacturing a quarter of the UK’s […]

  • Coronavirus: UK expert urges people in 20s to keep getting vaccine

    Prof David Spiegelhalter says advantages of vaccinating young people far outweigh risks Coronavirus – latest updates See all our coronavirus coverage People in their 20s should continue to get vaccinated against Covid despite the very rare cases of blood clotting linked to the Oxford/AstraZeneca vaccine because of the wider benefit to their families, friends and […]

  • UK ministers silent on AstraZeneca vaccine shipment to Australia

    Downing Street will not confirm or deny report that more than 700,000 Covid jabs were sent after EU blocked export Coronavirus – latest updates See all our coronavirus coverage British ministers and officials did not deny that more than 700,000 shots of the AstraZeneca vaccine were secretly dispatched from the UK to Australia a few […]

  • A prized UK biotech firm looks to Wall Street, much to Rishi Sunak’s dismay

    Vaccitech, the Oxford-based firm behind the AstraZeneca vaccine, is a high-profile float that slipped away A glowing, Deliveroo-style tribute from Rishi Sunak will not be required for this flotation. Vaccitech, the Oxford-based firm that owns some of the key biotechnology behind the AstraZeneca Covid vaccine, is off to New York for a public listing. One […]

  • Under-30s may have ‘small delay’ in getting Covid jab, says Jonathan Van-Tam

    England’s deputy chief medical officer says delay would be precaution against rare side-effect of blood clots Coronavirus – latest UK updates See all our coronavirus coverage People under 30 have been told there may be a “small delay” to when they will receive a coronavirus vaccine, given adults in that age group are now being […]

  • AstraZeneca jab: UK government says concerns being investigated thoroughly

    People urged to keep getting Covid vaccine, with EMA and MHRA expected to give updates on investigation into rare blood clots Coronavirus – latest updates See all our coronavirus coverage Government advisers say concerns over the Oxford/AstraZeneca jab are being taken “very seriously” and “very thoroughly” investigated, before an imminent announcement by the vaccines regulator. […]

  • EU blames AstraZeneca ‘failure’ for sluggish Covid vaccine rollout

    Anglo-Swedish company ‘solely’ to blame, says EU commissioner as bloc misses April vaccination target AstraZeneca has been squarely blamed by the EU for its comparatively slow Covid vaccine rollout after the bloc of 27 states failed to achieve its target to vaccinate 80% of older people by the end of March. Thierry Breton, the EU […]

  • Two new vaccines on the way – with more to follow this year

    Half of UK adults have had a first jab, and future supplies of millions of doses look assured Coronavirus – latest updates See all our coronavirus coverage Two very different jabs have been responsible for inoculating Britain’s strikingly high number of vaccine recipients – with more than half of the country’s adult population having now […]

  • Pfizer vaccine has 91% efficacy for up to six months, trial shows

    Findings based on two doses three weeks apart are first to show shot remains effective for many months Coronavirus – latest updates See all our coronavirus coverage The coronavirus vaccine developed by Pfizer and its German partner BioNTech protects against symptomatic Covid for up to six months, an updated analysis of clinical trial data has […]

  • Pfizer finds Covid vaccine safe and effective for children 12 to 15

    Drug firm in partnership with BioNTech to seek US approval after trials found vaccine ‘well-tolerated’ in school-age children Pfizer plans to seek emergency approval for its Covid vaccine in younger people after a US trial found the jab prevented the disease and was “well-tolerated” in 12- to 15-year-olds. Related: Germany restricts use of AstraZeneca jab […]

  • ‘Vaccine prince’: the Indian billionaire set to make Covid jabs for the UK

    Serum Institute boss Adar Poonawalla has rented a Mayfair mansion for £50,000 a week Coronavirus – latest updates See all our coronavirus coverage The AstraZeneca vaccine has made Prof Sarah Gilbert – who led the Oxford team that created it – one of the UK’s most famous modern scientists and turned the Anglo-Swedish pharmaceutical company […]

  • GSK fires former US vaccine chief Moncef Slaoui over harassment allegation

    Drugmaker dismisses former research boss from role at Galvani Bioelectronics GSK has dismissed its former research boss Moncef Slaoui, who became US national vaccine chief under Donald Trump, after an independent investigation found that he sexually harassed one of its female employees. GSK said it had terminated Slaoui’s role at Galvani Bioelectronics, a joint venture […]

  • Why a fresh AstraZeneca fightback is required in Covid vaccine info row | Nils Pratley

    Drugmaker isn’t entirely blameless but making it a political football for EU’s failures is simply ugly The European Union ought to be delighted. The “discovery” of a “stockpile” of 29m vaccine doses in Italy is really a non-discovery. The consignment is held at an authorised plant, available for inspection, and is merely awaiting quality sign-off. […]

  • AstraZeneca dismisses claim 29m vaccine doses in Italy were bound for UK

    Batches were found when Italian police searched factory at request of European commission Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has dismissed as “inaccurate” a report in the Italian press that 29m doses of its Covid-19 vaccine found in factory near Rome were destined for the UK. La Stampa reported on Wednesday […]

  • EU to widen criteria for possible Covid vaccine export bans

    Bloc expected to assess countries’ Covid vaccination coverage and record in facilitating exports to EU Coronavirus – latest updates See all our coronavirus coverage The EU is expected to take into account the level of vaccination coverage in a country and its record in facilitating exports to the bloc when deciding on whether to prohibit […]

  • US agency questions AstraZeneca’s Covid vaccine trial data

    Drug firm may have provided incomplete view of efficacy data from US trial, says safety monitor Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca vaccine against Covid has been dealt another blow within hours of AstraZeneca posting excellent results from its long-awaited big trial in the US. Questions have been raised in […]

  • Patrick Vallance: the adviser who spoke scientific truth to power

    The UK’s chief scientific adviser loves good food, enjoys a Scandi drama – and has been called ‘the richest civil servant in history’ Sir Patrick Vallance spent his 60th birthday at a podium in Downing Street, flanking Boris Johnson. Whatever plans he had were scrapped. Continue reading…

  • Patrick Vallance: the adviser who spoke scientific truth to power

    The UK’s chief scientific adviser loves good food, enjoys a Scandi drama – and has been called ‘the richest civil servant in history’ Sir Patrick Vallance spent his 60th birthday at a podium in Downing Street, flanking Boris Johnson. Whatever plans he had were scrapped. Continue reading…

  • How are Covid vaccines produced and why have there been delays?

    The newness of some of the technology and gaps in global preparedness have led to bottlenecks Coronavirus – latest updates See all our coronavirus coverage When the first Covid-19 vaccines were approved in the UK and elsewhere three months ago, many thought the end of the pandemic was almost within reach. Few, however, had anticipated […]

  • How are Covid vaccines produced and why have there been delays?

    The newness of some of the technology and gaps in global preparedness have led to bottlenecks Coronavirus – latest updates See all our coronavirus coverage When the first Covid-19 vaccines were approved in the UK and elsewhere three months ago, many thought the end of the pandemic was almost within reach. Few, however, had anticipated […]

  • The FCA’s criminal prosecution of NatWest could cause real damage

    Civil cases lost by other banks only led to financial penalties, but the verdict here may hit its reputation NatWest had “resolved all its major legacy issues”, declared Sir Howard Davies, the chairman, 18 months ago, speaking far too soon. Here comes another potential nasty one. The Financial Conduct Authority is bringing criminal charges under […]

  • The FCA’s criminal prosecution of NatWest could cause real damage

    Civil cases lost by other banks only led to financial penalties, but the verdict here may hit its reputation NatWest had “resolved all its major legacy issues”, declared Sir Howard Davies, the chairman, 18 months ago, speaking far too soon. Here comes another potential nasty one. The Financial Conduct Authority is bringing criminal charges under […]

  • Purdue Pharma unveils $10bn opioid settlement plan to exit from bankruptcy

    Plan is backed by $4bn from Sackler family Most parties onboard but Democratic attorneys general oppose Purdue Pharma is proposing a $10bn plan to emerge from bankruptcy that calls for it to be transformed into a company funnelling profits into the fight against the opioid crisis. Those efforts would include a significant boost – more […]

  • Purdue Pharma unveils $10bn opioid settlement plan to exit from bankruptcy

    Plan is backed by $4bn from Sackler family Most parties onboard but Democratic attorneys general oppose Purdue Pharma is proposing a $10bn plan to emerge from bankruptcy that calls for it to be transformed into a company funnelling profits into the fight against the opioid crisis. Those efforts would include a significant boost – more […]

  • What price a child’s life? India’s quest to make rare disease drugs affordable

    Parents whose only hope was finding foreign sponsorship or a clinical trial are now looking for homegrown breakthroughs For three years, Vidya tried to find the cause of her son’s recurrent fevers and low cognitive development. When she found out, she was devastated. Vineeth, 10, has an incurable illness – mucopolysaccharidosis type 2 – that […]

  • Ireland suspends AstraZeneca Covid vaccine over blood clot concerns

    Deployment of Oxford vaccine temporarily deferred after latest reports from Norway Coronavirus – latest updates See all our coronavirus coverage Ireland is suspending use of the Oxford/AstraZeneca vaccine against Covid as a precautionary measure following further reports of blood clots in people who have received it, this time from Norway. The deputy chief medical officer, […]

  • Israeli real-world data on Pfizer vaccine shows high Covid protection

    Jab has 97% efficacy against disease and death and 94% against infection without symptoms The Pfizer/BioNTech vaccine appears to give high protection against asymptomatic Covid-19, according to data from Israel – a finding that will boost hopes that mass vaccination can stop the spread of the virus. The top line of the real-world results, issued […]

  • From Pfizer to Moderna: who’s making billions from Covid vaccines?

    The companies in line for the biggest gains – and the shareholders who have already made fortunes Coronavirus – latest updates See all our coronavirus coverage The arrival of Covid-19 vaccines promises a return to more normal life – and has created a global market worth tens of billions of dollars in annual sales for […]

  • Italy blocks export of 250,000 AstraZeneca vaccine doses to Australia

    Row continues between EU and drug firm after shortfall in vaccine deliveries to bloc Coronavirus – latest updates See all our coronavirus coverage Italy has blocked the export of 250,000 doses of the Oxford/AstraZeneca vaccine to Australia in an escalation of a row with the Anglo-Swedish company. In the first such intervention under the EU’s […]

  • Thalidomide scandal: Sunak pledges lifetime support for survivors

    Joy and relief from campaigners as chancellor’s budget extends support that had been due to run out in 2023 Analysis: Sunak digs in for battle against financial cost of Covid Budget 2021: key points at a glance Budget 2021 live: Sunak to freeze income tax thresholds Thalidomide campaigners have reacted with relief and joy after […]

  • Covid: Germany and France under pressure to shift Oxford vaccine

    Both countries urged to take action to avoid pile-up of unused AstraZeneca vaccine doses Coronavirus – latest updates See all our coronavirus coverage Authorities in Germany and France are under pressure to come up with creative solutions to shift the AstraZeneca vaccine at higher speed in order to avoid a pile-up of unused doses over […]

  • Johnson & Johnson one-shot Covid vaccine gets nod from FDA advisory panel

    Vaccine, along with those from Pfizer and Moderna, should provide US with more than enough supply to vaccinate every person The battle against Covid-19 took a major step forward on Friday as the US moved closer to distributing its first one-shot Covid-19 vaccine, after an independent expert advisory panel recommended drug regulators authorize the Johnson […]

  • Blair says collaboration on Covid could have cut three months off crisis

    Former prime minister tells the Guardian the world must be better prepared for the next pandemic World leaders could have cut the length of the Covid outbreak by three months if they had collaborated on vaccines, testing and drugs, Tony Blair has claimed as he launched a report on preparing for the next deadly pandemic. […]

  • Moderna forecasts $18bn in sales of Covid vaccine this year

    Better than expected revenues will push US firm founded in 2010 into profit for first time Coronavirus – latest updates See all our coronavirus coverage Moderna expects to rake in $18.4bn (£13bn) of sales from its coronavirus vaccine this year, marking a huge turnaround in the fortunes of the US biotech firm. The expected revenue […]

  • Sussex medicines firm takes production line abroad in white van to beat Brexit ban

    UK assembly line at standstill as pharmaceutical company sets up in Amsterdam and plans EU expansion A Sussex pharmaceutical company has told how it had to bundle a production line into a white van and take it to Amsterdam to beat a Brexit medicines ban. The impromptu four-wheeled mission to the Netherlands has secured the […]

  • Drug companies look to AI to end ‘hit and miss’ research

    Technology that speeded the development of Covid vaccines has potential to transform the pharmaceutical industry The hunt for new medicines has often been more like a game of roulette than high-end science. But now the pharmaceutical sector is on the cusp of a transformation, as it delves into cutting-edge technology to come up with new […]

  • German politicians counter AstraZeneca vaccine scepticism with show of support

    Oxford Covid vaccine described in German media as ‘shelf warmer’ with only 17% of doses administered so far Coronavirus – latest updates See all our coronavirus coverage Politicians in Germany are stepping out in support of the AstraZeneca vaccine as public scepticism around the Oxford-developed product is threatening to hamper Europe’s Covid-19 immunisation programme. The […]

  • Shell strategy looking like a bundle of compromises | Nils Pratley

    Investors will get a vote on oil company’s plan to cruise down the middle lane Shell billed its net-zero by 2050 plan as an “acceleration” of strategy, which was a generous self-assessment. In today’s Big Oil terms, the approach is a cruise down the middle lane – a tweak here and there, but nothing to […]

  • AstraZeneca says vaccine against new Covid variants may take six months

    Anglo-Swedish pharmaceutical firm’s profits rise to $7.4bn as main business ‘remains strong’ Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has said it could take between six and nine months to produce Covid-19 vaccines that are effective against new variants of the coronavirus. The company’s vaccine, developed jointly with scientists at the University […]

  • Lonza to Divest Specialty Ingredients Business to Bain Capital and Cinven for $4.7B

    Shots: Bain Capital and Cinven to acquire Lonza’s specialty ingredients business and operations for an enterprise value of $4.7B. The transaction is expected to close in H2’21 The divestiture will allow Lonza to refocus its business as a pure-play partner to the healthcare industry Lonza’s specialty ingredients business provides microbial control solutions for Professional Hygiene […]

  • A series of knocks: Oxford/AstraZeneca’s bumpy road to Covid vaccine confidence

    From doubts about safety in older people to questions about variants, scientists have faced a battle to convince the public and regulators Coronavirus – latest updates See all our coronavirus coverage The Oxford University/AstraZeneca vaccine against Covid has barely been out of the news from the moment the race to protect the world’s population from […]

  • AstraZeneca set to weather Covid in better health than rivals

    The Anglo-Swedish firm already had a strong lineup of cancer drugs when vaccine success gave it a further boost Before the pandemic, AstraZeneca was highly regarded in the business and pharmaceutical world – seen as one of the UK’s best companies. Now, thanks to Britain’s successful vaccine programme, it is a household name. The Anglo-Swedish […]

  • GSK and CureVac sign £132m deal to develop multi-variant Covid vaccine

    Companies hope to have next generation of vaccines against emerging variants by next year GlaxoSmithKline and Germany’s CureVac have reached a €150m (£132m) agreement to develop a next generation of Covid-19 vaccines targeting new emerging variants in the pandemic. The two companies said they they plan to work jointly to develop a vaccine that can […]

  • EU Covid incompetence leaves governments wanting vaccines, not excuses | Larry Elliott

    Centralised approach was meant to underline Europe’s solidarity but has had opposite effect The EU has made an almighty hash of procuring treatments for Covid-19. Vaccine centres are running short of supplies as a result. National governments want jabs rather than excuses for what has gone wrong. The search for scapegoats is on. Stripped of […]

  • EU could block millions of Covid vaccine doses from entering UK

    European commission says new mechanism will give national regulators power to refuse exports Coronavirus – latest updates See all our coronavirus coverage Millions of doses of vaccines could be blocked from entering Britain from the EU within days, as part of Brussels’ response to a shortage of doses among its member states. The European commission […]

  • The EU’s vaccine bust-up with AstraZeneca is of its own making | Leo Cendrowicz

    Slowness to sign up to and approve the vaccine may have caused delays, but Brussels feels the company is being less than cooperative Coronavirus – latest updates See all our coronavirus coverage Last year AstraZeneca was heralded for its pioneering vaccine discovery. Yet today the British-Swedish pharmaceutical company is embroiled in a dispute with the […]

  • EU Covid vaccines row: AstraZeneca boss reveals problems

    Pascal Soriot has provided the deepest insight yet into supply issues The chief executive of AstraZeneca has dismissed suggestions that the UK is being unfairly prioritised for Covid-19 vaccine doses, in a wide-ranging interview revealing “glitches” that have constrained production. Pascal Soriot offered the deepest insight yet into a scientific process that has been dragged […]

  • EU means business over Covid vaccine exports, says Von der Leyen

    Commission president says firms must deliver on orders after AstraZeneca warns of shortfall Coronavirus – latest updates See all our coronavirus coverage The EU “means business”, Ursula von der Leyen has said, as the bloc doubled down on plans for tighter monitoring of vaccine exports to countries outside of the union, such as the UK. […]

  • EU’s Covid vaccination debacle is down to institutional inflexibility

    Supply delays underline there was no legal or economic justification for central planning A storm is raging over the EU’s failure to have ordered more of the approved Covid-19 vaccines ahead of time. Stéphane Bancel, the CEO of the US pharmaceutical company Moderna, which gained approval for its vaccine shortly after Pfizer/BioNTech, claims that the […]

  • Sector by sector: are British firms ready for post-Brexit trade?

    Analysis: From retail to aviation to pharmaceuticals, we look at what will change from 1 January After months of tortuous negotiations between the UK and the EU, a Brexit trade deal was agreed at almost the last minute. But how prepared are UK businesses for the significant changes that will come into force on 1 […]

  • ‘Happy vaccine day’ at Welsh factory proudly preparing Oxford doses

    Staff at Wockhardt in Wrexham buzzing at news of approval after working over Christmas Most of the sprawling industrial estate on the edge of Wrexham was quiet. There was little sign of activity at the engineering firms or in the self-storage units or greasy spoon cafes. But behind the wire fence of the Wockhardt UK […]

  • ‘I’ve never seen anything like it’: 2020 smashes records in global markets

    From worst crash in a generation to record highs on news of a Covid vaccine, experts review the rollercoaster that was 2020 Coronavirus – latest updates See all our coronavirus coverage 2020 has been the most remarkable year for the global financial markets. After the Covid-19 pandemic triggered the worst crash in a generation, unprecedented […]

  • UK scientists trial drug to prevent coronavirus infection leading to disease

    Exclusive: antibody therapy could confer instant immunity against Covid-19 to at-risk groups See all our coronavirus coverage British scientists are trialling a new drug that could prevent someone who has been exposed to coronavirus from going on to develop the disease Covid-19, which experts say could save many lives. The antibody therapy would confer instant […]

  • Servier to Acquire Agios’ Oncology Business for ~$2B

    Shots: Agios to receive ~$1.8B upfront in cash & ~$200M as regulatory milestones for Vorasidenib along with 5% royalties on sales of Tibsovo in the US from transaction close through the loss of exclusivity and 15% royalties on sales of vorasidenib in the US from first commercial sale through the loss of exclusivity The acquisition […]

  • Government ‘operated illegal buy British policy’ over Covid contracts

    Other firms better placed to supply antibody tests, argues case against health secretary Matt Hancock Coronavirus – latest updates See all our coronavirus coverage The government was operating an illegal “buy British” policy when it signed contracts with a small UK firm to supply Covid antibody tests, claim lawyers who have filed a case against […]

  • British American Tobacco wins approval to test Covid vaccine on humans

    Treatment grown on tobacco plants gets US backing for clinical study Coronavirus – latest updates See all our coronavirus coverage British American Tobacco has moved a step closer to producing a vaccine for coronavirus using tobacco plants, as it won approval in the US to begin testing on humans. The company behind cigarette brands including […]

  • Scheme to get Covid vaccine to poorer countries at ‘high risk’ of failure

    Risk assessment documents say cost, delays and shortages could lead to billions not vaccinated until 2024 Coronavirus – latest updates See all our coronavirus coverage The global scheme to deliver Covid-19 vaccines to poorer countries faces a “very high” risk of failure, potentially leaving billions of people with no access to vaccines until as late […]

  • Ministers would be wise to play for time before ordering Sizewell C | Nils Pratley

    Dashing ahead with a nuclear power station that’s modelled on Hinkley Point C would be reckless This is the government’s problem as it reopens talks on a proposed nuclear power station at Sizewell C in Suffolk: it is contemplating ordering a replica of Hinkley Point C before the Somerset original has produced a single megawatt […]

  • AstraZeneca shares slump after it agrees $39bn Alexion buyout

    Britain’s biggest drugmaker offers 45% premium for shares of US rare diseases specialist AstraZeneca shares fell sharply after it agreed to a $39bn (£29bn) takeover of the US rare diseases specialist Alexion, the biggest deal in its history if it goes ahead. Investors sold off shares in the Anglo-Swedish drugmaker over fears it was paying […]

  • Deal or no deal: how life will look for key industries after Brexit

    Companies are praying a trade agreement can be struck, but must prepare for talks to fail. Which will be most affected? The scene is set for a showdown, and the future of the UK economy is at stake. Will Britain secure a free trade deal with the EU? Or will the prime minister choose to […]

  • Can the UK deliver on the Covid vaccine rollout? | Stephen Buranyi

    The challenge of delivering vaccines on this scale are hard, but are firmly within the world of logistics, engineering, and politics Coronavirus – latest updates See all our coronavirus coverage The UK has become the first country to approve one of the coronavirus vaccines that the entire world has been desperately waiting for. And on […]

  • Covid vaccines offer chance for big pharma to improve its image

    They make life-saving medicines, but no one likes them. Could this year be a turning point? Coronavirus – latest updates See all our coronavirus coverage Never before has the world awaited a new medicine with such bated breath. A vaccine for Covid-19 has the potential to unlock society and save millions of people from death […]

  • Boston Scientific to Divest BTG’s Specialty Pharma Business for ~$800M

    Shots: Boston Scientific signs an agreement with Stark International and SERB SAS to sell its BTG specialty pharma business for $800M in cash. The transaction is expected to close in H1’21 The agreement includes the transfer of 5 facilities & ~280 employees globally. This transaction will help the BTG specialty pharma business enhance its potential […]

  • How does the Pfizer/BioNTech vaccine work and who will get it?

    Covid vaccine with an efficacy of almost 95% has been authorised by the UK medicines regulator Coronavirus – latest updates See all our coronavirus coverage The Pfizer/BioNTech Covid vaccine, which has an efficacy of almost 95%, has been authorised by the UK medicines regulator, making the UK the first western country to license a vaccine […]